The Multisystem Impact of Long COVID: A Comprehensive Review
Authors:
- Nicoleta NegrutNicoleta Negrut
- Menegas GeorgiosMGMenegas Georgios
- Sofia KampiotiSKSofia Kampioti
- Maria BourelouMBMaria Bourelou
- Francesca KopanyiFKFrancesca Kopanyi
- Faiso Dahir HassanFHFaiso Dahir Hassan
- Anamaria AsowedAAAnamaria Asowed
- Fatima Zohra TaleouineFTFatima Zohra Taleouine
- Anca FericianAFAnca Ferician
- Paula MarianPMPaula Marian
Preprint
- 3 January 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
(1) Background: COVID-19 was responsible for the latest pandemic, shaking and reshaping healthcare systems worldwide. Its late clinical manifestations make it linger in medical memory as a debilitating illness over extended periods. (2) Methods: Recent literature was systematically analyzed to categorize and examine the symptomatology and pathophysiology of Long COVID across various bodily systems, including pulmonary, cardiovascular, gastrointestinal, neuropsychiatric, dermatological, renal, hematological, and endocrinological aspects. (3) Results: The review outlines the diverse clinical manifestations of Long COVID across multiple systems, emphasizing its complexity and challenges in diagnosis and treatment. Factors such as pre-existing conditions, initial COVID-19 severity, vaccination status, gender, and age were identified as influential in the manifestation and persistence of Long COVID symptoms. This condition is highlighted as a debilitating disease capable of enduring over an extended period and presenting new symptoms over time. (4) Conclusions: Long COVID emerges as a condition with intricate multi-systemic involvement, complicating its diagnosis and treatment. The findings underscore the necessity for a nuanced understanding of its diverse manifestations to effectively manage and address the evolving nature of this condition over time.Keywords
All Related Versions
This publication has 154 references indexed in Scilit:
- Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal StudyJournal of Clinical Immunology, 2021
- Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Dermatology, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanismsInflammation Research, 2020
- CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patientsEuropean Radiology, 2020
- SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimensJournal of Medical Virology, 2020
- The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patientsJournal of Medical Virology, 2020
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetIntensive Care Medicine, 2020
- Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoVJournal of Medical Virology, 2020
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004